Indication
Myelodysplasia
2 clinical trials
2 products
Product
PRT543Clinical trial
A Phase 1, Open-Label, Multicenter, Dose Escalation, Dose Expansion Study of PRT543 in Patients With Advanced Solid Tumors and Hematologic MalignanciesStatus: Completed, Estimated PCD: 2022-11-16
Clinical trial
Efficacy and Safety of Luspatercept in Adult Patients With Transfusion-dependent Anemia Due to Very Low-, Low- and Intermediate-risk (IPSS-R) Myelodysplastic Syndrome With Ring Sideroblasts: a Retrospective Multicenter Study by FISiM-ETSStatus: Completed, Estimated PCD: 2022-12-31
Product
Luspatercept